The 'liver-first approach' for patients with locally advanced rectal cancer and synchronous liver metastases

Diseases of the Colon and Rectum

Volumn 52, Issue 1, 2009, Pages 23-30

  Verhoef, Cornelis ^a   Van Der Pool, Anne E M ^a   Nuyttens, Joost J ^a   Planting, Andre S T ^a   Eggermont, Alexander M M ^a   De Wilt, Johannes H W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Liver first approach; Locally advanced rectal cancer; Synchronous liver metastases

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; LIVER METASTASIS; LIVER RESECTION; MALE; RADIATION DOSE; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECTUM SURGERY; SURGICAL APPROACH; TREATMENT FAILURE; TREATMENT RESPONSE; ADENOCARCINOMA; ADJUVANT THERAPY; LIVER TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RECTUM TUMOR;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LAPAROTOMY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; TREATMENT FAILURE;

EID: 64049090266     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e318197939a     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Gosens MJ, Klaassen RA, Tan-Go I, et al. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 2007;13:6617-23.
3. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
4. Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-5.
5. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355:1114-23.
6. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 1999;16:459-67.
7. de Bruin AF, Nuyttens JJ, Ferenschild FT, Planting AS, Verhoef C, de Wilt JH. Preoperative chemoradiation in patients with locally advanced rectal cancer. Neth J Med 2008;66:71-6.
8. Ferenschild FT, Vermaas M, Nuyttens JJ, et al. Value of intraoperative radiotherapy in locally advanced rectal cancer. Dis Colon Rectum 2006;49:1257-65.
9. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. EJC 2002;38: 1023-33.
10. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10- year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007;25:4575-80.
11. Sperti E, Faggiuolo R, Gerbino A, et al. Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach. Dis Colon Rectum 2006;49:1596-601.
12. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008;247:125-35.
13. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644-57.
14. Kornprat P, Jarnagin W, Gonen M, et al. Outcome after hepatectomy for multiple or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14:1151-60.
15. Chua HK, Sondenaa K, Tsiotos GG, Larson DR, Wolff BG, Nagorney DM. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 2004;47:1310-6.
16. Minagawa M, Yamamoto J, Miwa S, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg 2006;141:1006-12.
17. Tanaka K, Shimada H, Matsuo K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004;136:650-9.
18. Thelen A, Jonas S, Benckert C, et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 2007;22:1269-76.
19. Vermaas M, Ferenschild FT, Hofer SO, Verhoef C, Eggermont AM, de Wilt JH. Primary and secondary reconstruction after surgery of the irradiated pelvis using a gracilis muscle flap transposition. Eur J Surg Oncol 2005;31:1000-5.
20. Vermaas M, Ferenschild FT, Verhoef C, et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 2007;33:452-8.
21. Adam R. Colorectal cancer with synchronous liver metastases. Br J Surg 2007;94:129-31.
22. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006;24:3939-45.
23. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1-7.
24. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003;7:109-15.
25. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy. A contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240: 1052-61.
26. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX 4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer. Lancet 2008;371:1007-16.
27. Peeters CF, de Waal RM, Wobbes T, Westphal JR, Ruers TJ. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer 2006;119:1249-53.
28. Benoist S, Pautrat K,Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005;92: 1155-60.
29. Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imagingdefined poor-risk rectal cancer. J Clin Oncol 2006;24: 668-74.
30. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastes before treatment of the colorectal primary. Br J Surg 2006;93:872-78.
31. Craven I, Haselden J, Miller KE, Miller GV, Bradford I, Sebag- Montefiore D. Omission of concurrent chemoradiation after a response to neoadjuvant chemotherapy in locally advanced rectal cancer with a synchronous liver metastasis: a note of caution. Br J Radiol 2007;80:257-9.